Skip to content
This website uses cookies to help us understand the way visitors use our website. We can't identify you with them and we don't share the data with anyone else. If you click Reject we will set a single cookie to remember your preference. Find out more in our privacy policy.

Management and Supervision Tool (MaST)

Management and Superverision Tool (MaST) is decision-support software which uses predictive analytics to facilitate the proactive review of people with mental ill-health in the community so that resources can be prioritised to prevent relapse. MaST enables identification of cohorts hardest hit by the pandemic such as BAME groups, older people, and those with long-term conditions.

  • Workforce support
  • Mental health
Management and Supervision Tool (MaST) logo

MaST (COV19 module) has been developed with support from Innovate UK and is already in use in Mersey Care NHS Foundation Trust to identify and protect people using mental health services who are also on the Shielded List as well as those who are vulnerable because of COVID-19 infection or restrictions.

The effective rebuild of Community Mental Health Services relies on implementation of the ‘Community Mental Health Framework’ (NHS England 2019) alongside lessons learned from the delivery of mental health care during the pandemic.

MaST provides decision-support to enable a collaborative multi-agency response, meeting the needs of local communities and addressing inequalities which have become more pronounced during the pandemic.

Impact

MaST has enabled improved use of NHS resources and the quality and safety of patient care enabling:

  • 7,312 high quality telephone assessments for vulnerable individuals over six weeks,
  • 2,381 shielded people with dementia and 1,107 with psychosis prioritised and assessed within two weeks to arrange appropriate support,
  • Data from different data sources to be aggregated
  • Staff that were required to be at home to work remotely, adding significant value to the NHS response.

The evaluation of MaST used during the lockdown highlighted benefits which are sustainable and will positively contribute to objectives set out in the NHS Response:

  • MaST enables the reduction of caseload sizes in Community Mental Health Teams which will be essential to successfully manage the anticipated surge in mental ill-health with an additional 500,000 people predicted to require access to services.
  • MaST supports multi agency working, enhancing communication between health and social care teams (especially GPs and Care Homes, Pharmacists, Drugs and Alcohol teams)
  • MaST reduces administration time and staff reported an enhanced sense of achievement and well-being.
  • MaST improved clinical prioritisation and because the most at risk and vulnerable people were contacted first, had a positive impact on service users.